2MNU

Backbone and side chain 1H, 13C, and 15N Chemical Shift Assignments for EDB and specific binding aptide

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	3D HNCACB	0.3 mM [U-100% 13C; U-100% 15N] EDB and APT-1	90% H2O/10% D2O	20	6	ambient	298
2	3D CBCA(CO)NH	0.3 mM [U-100% 13C; U-100% 15N] EDB and APT-1	90% H2O/10% D2O	20	6	ambient	298
3	3D HCCH-TOCSY	0.3 mM [U-100% 13C; U-100% 15N] EDB and APT-1	90% H2O/10% D2O	20	6	ambient	298
4	3D 1H-13C NOESY	0.3 mM [U-100% 13C; U-100% 15N] EDB and APT-1	90% H2O/10% D2O	20	6	ambient	298
5	3D 1H-15N NOESY	0.3 mM [U-100% 13C; U-100% 15N] EDB and APT-1	90% H2O/10% D2O	20	6	ambient	298

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	900

NMR Refinement
Method	Details	Software
simulated annealing		X-PLOR NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	50
Conformers Submitted Total Number	20
Representative Model	1 (fewest violations)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	chemical shift assignment	X-PLOR NIH		Garrett
2	refinement	X-PLOR NIH		Garrett
3	chemical shift assignment	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore
4	refinement	X-PLOR NIH		Schwieters, Kuszewski, Tjandra and Clore

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.